FDA Inspection
Bristol-Myers Squibb CompanyBristol-Myers Squibb Company – FDA Inspection, Nov 20, 2008
Record Details
This FDA Inspection record concerns Bristol-Myers Squibb Company, with an inspection on November 20, 2008, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bristol-Myers Squibb Company
- Inspection Date
- November 20, 2008
- Product Type
- Drugs
View Company Profile
ID · fa38d6fd-880e-4dc3-bfd8-cef8d0aa3237
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 547474
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bristol-Myers Squibb Company
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 12, 2025 | Not classified | New Jersey District Office | |
| December 1, 2023 | Not classified | New Jersey District Office | |
| October 13, 2017 | Not classified | New Jersey District Office | |
| November 22, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 22, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bristol-Myers Squibb Company
- FDA Inspection 1299176 - 2025-12-12
- FDA Inspection 1228554 - 2023-12-01
- FDA Inspection 1034312 - 2017-10-13
- FDA Inspection 857661 - 2013-11-22
- FDA Inspection 652918 - 2010-03-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.